?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
518 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
518 Unternehmen gefunden • Seite 9 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | YungShin Global Holding Corp | 48.0 | Arzneimittel (Pharmazeutisch) | Taiwan | 0.5 Mrd. USD | 16.58 | 16.65 | 1.90 | 1.91 | ▲ 0.71% | ▲ 2.16% | 5.38% | - | 1 Jahre | 10.52% | ▲ 0.52% | 15.71% | ▲ 1.25% | 12.00% | ▲ 0.70% | 5 / 9 | 6,44 | > 50-fach | 31 / 100 | −5,4 / 100 | −3,87 |
| Walvax BioTech | 47.9 | Arzneimittel (Biotechnologie) | China | 3.1 Mrd. USD | 110.90 | - | 9.98 | 3.00 | ▼ -3.89% | ▼ -29.26% | 1.18% | ▲ 20.11% | - | 7.37% | ▼ -1.92% | 2.90% | ▼ -5.34% | -0.63% | ▲ 3.68% | 6 / 9 | 6,55 | > 50-fach | 15 / 100 | −2,9 / 100 | −2,72 |
| Sichuan Kelun Pharmaceutical Co Ltd | 47.5 | Arzneimittel (Pharmazeutisch) | China | 9.3 Mrd. USD | 34.22 | - | 3.43 | 2.54 | ▲ 2.37% | ▲ 15.46% | 1.51% | - | - | 9.19% | ▲ 1.01% | 13.44% | ▲ 2.04% | 5.51% | ▼ -0.93% | 5 / 9 | 6,09 | 17-fach | 25 / 100 | −2,7 / 100 | −4,43 |
 | Organogenesis Holdings Inc | 47.4 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | 9.20 | 0.42 | 0.67 | ▲ 10.73% | ▲ 15.59% | - | - | - | 6.58% | ▼ -3.07% | 9.92% | ▼ -1.63% | -4.34% | ▼ -1.90% | 5 / 9 | 6,17 | 10-fach | 71 / 100 | 7,9 / 100 | −1,46 |
| PharmaBlock Sciences Nanjing Inc Class A | 47.3 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | 45.63 | - | 4.55 | 2.11 | ▲ 14.07% | ▼ -0.05% | 0.92% | - | - | 9.31% | ▼ -6.91% | 12.90% | ▼ -6.00% | 26.70% | ▲ 12.84% | 6 / 9 | 9,18 | 5-fach | 8 / 100 | −6,6 / 100 | −1,49 |
| Humanwell Healthcare Group Co Ltd | 46.5 | Arzneimittel (Pharmazeutisch) | China | 4.5 Mrd. USD | 14.74 | 139.10 | 1.25 | 1.55 | ▲ 2.99% | ▲ 13.03% | 2.62% | - | 3 Jahre | 7.74% | ▼ -0.39% | 15.96% | ▲ 0.42% | 7.45% | ▲ 1.78% | 7 / 9 | 4,86 | 9-fach | 34 / 100 | −2,0 / 100 | −2,84 |
| China Resources Pharmaceutical Group Ltd | 46.3 | Arzneimittel (Pharmazeutisch) | Hong Kong | 3.4 Mrd. USD | 4.88 | 1.20 | 0.07 | 0.37 | ▲ 12.21% | ▲ 6.43% | 5.64% | - | - | 1.50% | ▼ -0.15% | 4.63% | ▲ 0.18% | 6.28% | ▲ 0.83% | 9 / 9 | 3,03 | 6-fach | 20 / 100 | −7,5 / 100 | −1,89 |
 | Biogen Inc | 46.3 | Arzneimittel (Biotechnologie) | USA | 32.1 Mrd. USD | 38.42 | 11.90 | 3.23 | 1.70 | ▼ -6.11% | ▼ -20.22% | - | - | - | 13.18% | ▼ -1.51% | 19.14% | ▼ -1.52% | 20.90% | ▼ -0.44% | 5 / 9 | 5,62 | 7-fach | 23 / 100 | −3,1 / 100 | −2,49 |
| GuangYuYuan Chinese Herbal Medicine Co Ltd | 46.2 | Arzneimittel (Pharmazeutisch) | China | 1.0 Mrd. USD | 99.82 | 61.75 | 4.59 | 3.89 | ▲ 4.30% | ▲ 14.52% | - | - | - | 4.60% | ▲ 11.15% | 10.14% | ▲ 13.87% | 14.00% | - | 6 / 9 | 4,14 | 28-fach | 38 / 100 | −5,6 / 100 | −3,87 |
| Apeloa Pharmaceutical Co Ltd | 46.2 | Arzneimittel (Pharmazeutisch) | China | 3.8 Mrd. USD | 29.90 | 69.92 | 2.77 | 3.87 | ▲ 4.37% | ▲ 1.75% | 4.30% | ▼ -0.41% | - | 9.13% | ▼ -0.39% | 9.01% | ▼ -0.65% | 8.65% | ▲ 1.78% | 7 / 9 | 4,41 | 32-fach | 19 / 100 | −2,8 / 100 | −2,60 |
 | CSL Ltd | 46.1 | Arzneimittel (Biotechnologie) | Australien | 57.3 Mrd. USD | - | 20.56 | 3.64 | 3.87 | ▲ 9.20% | - | 2.45% | ▲ 7.45% | 4 Jahre | -16.43% | ▼ -7.30% | 25.55% | ▲ 1.02% | 18.26% | ▼ -1.26% | 5 / 9 | 2,83 | 3-fach | 24 / 100 | −19,4 / 100 | −3,38 |
 | Genomma Lab Internacional S.A.B. de C.V | 45.9 | Arzneimittel (Pharmazeutisch) | Mexiko | 0.7 Mrd. USD | 10.40 | 10.52 | 0.98 | 1.05 | ▲ 4.81% | ▲ 1.88% | 6.28% | - | 2 Jahre | 9.20% | ▲ 0.13% | 21.41% | ▲ 0.59% | 11.56% | ▲ 1.52% | 4 / 9 | 5,04 | 4-fach | 46 / 100 | −1,8 / 100 | −2,60 |
| Alphamab Oncology | 45.4 | Arzneimittel (Biotechnologie) | China | 1.0 Mrd. USD | - | - | 12.83 | 3.94 | ▲ 156.25% | ▼ -33.17% | - | - | - | -20.12% | ▲ 74.58% | -27.07% | ▲ 76.76% | -27.83% | ▲ 88.75% | 2 / 9 | 4,87 | −4,3-fach | 20 / 100 | 0,5 / 100 | −0,77 |
| Abbisko Cayman Ltd | 45.4 | Arzneimittel (Biotechnologie) | China | 0.8 Mrd. USD | - | - | 53.76 | 2.40 | - | - | - | - | - | 9.27% | ▲ 1495.07% | 4.56% | ▲ 844.34% | 12.37% | ▲ 531.92% | 7 / 9 | 4,47 | −33,2-fach | 25 / 100 | −1,0 / 100 | - |
| Shanghai Yizhong Pharmaceutical Co Ltd | 44.9 | Arzneimittel (Pharmazeutisch) | China | 1.2 Mrd. USD | 114.42 | - | 24.27 | 5.25 | - | - | - | - | - | 20.23% | ▲ 18.00% | 19.58% | ▲ 43.57% | -47.14% | ▲ 239.76% | 6 / 9 | 18,68 | > 50-fach | 21 / 100 | 5,5 / 100 | −1,64 |
 | Swedish Orphan Biovitrum AB (publ) | 44.1 | Arzneimittel (Pharmazeutisch) | Schweden | 15.7 Mrd. USD | 110.61 | 21.08 | 4.99 | 3.62 | ▲ 13.10% | ▼ -31.82% | - | - | - | 1.69% | ▼ -3.02% | 28.50% | ▲ 1.02% | 30.19% | ▼ -0.50% | 5 / 9 | 2,35 | 3-fach | 18 / 100 | −12,0 / 100 | −2,60 |
| Zhejiang Hisun Pharmaceutical Co Ltd | 43.8 | Arzneimittel (Pharmazeutisch) | China | 2.0 Mrd. USD | 18.71 | 14.10 | 1.27 | 1.47 | ▼ -1.46% | ▲ 5.32% | 1.89% | ▲ 27.73% | 1 Jahre | 5.13% | ▲ 0.43% | 12.14% | ▲ 1.45% | 15.69% | ▲ 1.94% | 7 / 9 | 2,31 | 4-fach | 32 / 100 | −10,1 / 100 | −3,20 |
 | Sandoz Group AG | 43.6 | Arzneimittel (Pharmazeutisch) | Schweiz | 35.3 Mrd. USD | 54.52 | 32.67 | 3.06 | 3.92 | ▲ 5.47% | ▲ 15.69% | 1.21% | - | 1 Jahre | 8.58% | ▼ -1.30% | 12.77% | ▲ 1.16% | 7.26% | ▼ -1.28% | 7 / 9 | 2,87 | 3-fach | 24 / 100 | −2,9 / 100 | −2,63 |
| Sumitomo Dainippon Pharma Co. Ltd | 43.5 | Arzneimittel (Pharmazeutisch) | Japan | 4.5 Mrd. USD | - | - | 2.19 | 4.41 | ▼ -2.56% | ▲ 13.71% | - | ▼ -18.10% | - | 23.58% | ▲ 4.63% | 23.18% | ▲ 4.61% | - | ▼ -0.75% | 5 / 9 | 2,23 | −6,3-fach | 32 / 100 | 13,3 / 100 | −1,17 |
 | Prestige Brand Holdings Inc | 43.5 | Arzneimittel (Pharmazeutisch) | USA | 2.2 Mrd. USD | 12.93 | 9.45 | 2.01 | 1.16 | ▲ 2.91% | ▲ 2.93% | - | - | - | 17.48% | ▲ 2.33% | 28.42% | ▲ 2.77% | 22.64% | ▲ 0.09% | 5 / 9 | 3,94 | 6-fach | 16 / 100 | −1,9 / 100 | −2,25 |
| Celltrion Pharm Inc | 43.0 | Arzneimittel (Pharmazeutisch) | Südkorea | 1.2 Mrd. USD | 40.67 | 42.20 | 3.02 | 3.88 | ▲ 18.09% | ▲ 13.10% | 0.51% | - | - | 7.22% | ▼ -0.50% | 10.46% | ▼ -0.52% | 12.77% | ▼ -0.16% | 8 / 9 | 4,26 | 6-fach | 22 / 100 | −6,3 / 100 | −2,71 |
 | Ascendis Pharma AS | 42.7 | Arzneimittel (Biotechnologie) | Dänemark | 17.3 Mrd. USD | 19.79 | 44.41 | 14.19 | 10.42 | ▲ 150.93% | ▼ -12.16% | - | - | - | -31.67% | ▲ 1083.55% | -18.92% | ▲ 1260.05% | 6.31% | ▲ 1228.74% | 5 / 9 | −7,33 | −4,6-fach | 45 / 100 | −20,8 / 100 | −2,61 |
| Dermapharm Holding SE | 42.4 | Arzneimittel (Pharmazeutisch) | Deutschland | 2.1 Mrd. USD | 12.64 | 10.81 | 1.57 | 3.45 | ▲ 7.97% | ▲ 9.06% | 2.35% | - | - | 11.37% | ▼ -2.52% | 19.03% | ▼ -3.06% | 11.97% | ▼ -2.67% | 7 / 9 | 3,05 | 4-fach | 18 / 100 | −2,2 / 100 | −1,96 |
| Guangdong Zhongsheng Pharmaceutical Co Ltd | 42.0 | Arzneimittel (Pharmazeutisch) | China | 3.0 Mrd. USD | 99.76 | - | 8.94 | 4.96 | ▲ 5.88% | - | 0.86% | - | - | 10.93% | ▼ -2.52% | 12.71% | ▼ -2.57% | -0.43% | ▼ -2.24% | 8 / 9 | 8,42 | 4-fach | 28 / 100 | −0,6 / 100 | −3,58 |
| Harbin Pharmaceutical Group Co Ltd | 41.8 | Arzneimittel (Pharmazeutisch) | China | 2.6 Mrd. USD | 56.82 | - | 1.10 | 3.00 | ▲ 8.15% | - | - | - | 1 Jahre | 2.27% | ▼ -0.07% | 4.58% | ▼ -0.04% | 1.81% | ▲ 0.78% | 6 / 9 | 3,36 | 13-fach | 31 / 100 | −0,6 / 100 | −2,78 |
